about
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver diseaseContrast-enhanced ultrasound in differentiating malignant from benign portal vein thrombosis in hepatocellular carcinomaThe risk of osteoporosis in patients with liver cirrhosis: a meta-analysis of literature studies.Enteropathic spondyloarthritis: from diagnosis to treatment.Percutaneous electrochemotherapy in the treatment of portal vein tumor thrombosis at hepatic hilum in patients with hepatocellular carcinoma in cirrhosis: A feasibility studyThe role of drainage after excision and primary closure of pilonidal sinus: a meta-analysis.Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies.Lipid profile changes in patients with rheumatic diseases receiving a treatment with TNF-α blockers: a meta-analysis of prospective studies.Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies.Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials.Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature.Viral hepatitis and anti-phospholipid antibodies positivity: A systematic review and meta-analysis.Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies.Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature.Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: a systematic review and meta-analysis of literature studies.Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies.Cardiovascular effects of Etanercept in patients with psoriatic arthritis: evidence from the cardiovascular risk in rheumatic diseases database.Cardiovascular risk markers in patients with primary aldosteronism: A systematic review and meta-analysis of literature studies.Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis.Impact of Vitamin D deficiency on subclinical carotid atherosclerosis: a pooled analysis of cohort studies.Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis.Assessment of Hemophilic Arthropathy by Ultrasound: Where Do We Stand?Impact of Valve Morphology on the Prevalence of Coronary Artery Disease: A Systematic Review and Meta-Analysis.Subclinical carotid atherosclerosis in patients with chronic obstructive pulmonary disease: a meta-analysis of literature studies.The risk of coronary artery disease and cerebrovascular disease in patients with hepatitis C: A systematic review and meta-analysis.The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature.Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures.Safety of warfarin in "high-risk" populations: A meta-analysis of randomized and controlled trials.Markers of atherosclerosis in patients with Cushing's syndrome: a meta-analysis of literature studies.Markers of subclinical atherosclerosis in patients with aortic valve sclerosis: A meta-analysis of literature studies.Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.Primary and Secondary Hemostasis in Patients With Subclinical Hypothyroidism: Effect of Levothyroxine Treatment.Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation. A systematic review and meta-analysis of the literature.Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia.Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.The risk of venous thromboembolism in patients with hepatitis C. A systematic review and meta-analysis.The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies.Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis
P50
Q26825517-B6BC3CC5-C71D-4C68-9B9A-11EA188559E3Q28085363-C2A78258-AD2F-4178-837B-5102C5CF6069Q35589088-3A604B3D-A720-4858-A056-136E0A989B67Q36830824-1BE5882C-31EB-40D8-9460-ED414C89DB99Q37629729-F7826EE4-A629-43FA-B1B3-4D0C6AA167B1Q38113512-AC12E93D-5DFA-460A-A0D0-4116187CCCC0Q38160766-01410FD9-B1F9-4043-A7C3-F9A83BC7A62AQ38181566-B629C64B-B4A9-42C1-B58B-079512667B81Q38259336-6106D76D-BC91-4628-A43A-C8A5C0A66E59Q38302442-6A06D11F-4F61-4823-8A14-53288352FAAFQ38384268-4FFE232D-C5FA-41D1-A51D-7CC5F96FA0F9Q38402084-C72D3640-072F-40A7-8166-42EDF07C8363Q38466181-40D41212-2731-46B1-BDF7-496A393F8016Q38486454-A200A898-3A40-458F-8314-A30F76A516F9Q38580767-9088B7E4-0290-439D-B16A-5F5BA5A03245Q38627709-8D752DE5-A230-4C2D-9238-65684CDD4769Q38653041-9ABAFC11-8075-4013-88F6-D9FBDD56E7A8Q38716745-3836F2CC-8C46-46A2-80F1-6C55729842ACQ38723199-C3CEA012-E21C-4DF0-87DC-B4D68EA61B2AQ38727616-84F40100-4920-4D49-B65A-46A56A5F9D49Q38737113-DEB6664F-2219-4A52-8028-AF82DE18237CQ38819927-5EF23813-B1D3-4278-8A82-F738D940D446Q38837842-E872037B-6C8B-495F-96E7-B88F64464175Q38888060-6FDD3AA6-0685-412A-8B85-FCE43F1BCFF8Q38900591-28F4CED9-1E7D-484A-9763-6B3FC702D95DQ39022742-A8DDD9AA-D0B8-49A0-A3A7-9DE6D4DDA281Q39037766-4E507F1A-B44F-4F5A-BA54-A79194FD3D2DQ39052406-DD5534AF-5AF2-4150-8D6A-E95C4B9A8DB1Q39092245-0D3C4D14-3026-446F-ADE8-D41A3325216CQ39267186-3DBE4810-1BFC-4F64-9B0A-AE57274578C9Q40614284-AFFDA82B-2B21-49E0-8D89-8BDC0182EF49Q47406652-54414AAE-F422-4296-85BA-462BA17F6A7BQ50556356-387BB9E7-0251-4173-BEC1-F9E9E77CC0B3Q50956686-C4F5F61A-9C88-4AF8-88D7-5845B8825543Q51305262-EA6B8045-5B58-4135-8779-28622B94CB34Q54255528-6EAFD940-F42C-498C-AE2E-FF02461B9B76Q54498836-190ACAAC-A60A-4D77-AC95-92B58B3E7792Q54564686-93594BFD-B0DD-4229-B081-4E3863F28809Q55058901-92C75213-85F1-4BD5-BD9E-EFFE19864ADCQ57398671-7A876145-888D-4495-B1EB-80D38342B93F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pasquale Ambrosino
@ast
Pasquale Ambrosino
@en
Pasquale Ambrosino
@es
Pasquale Ambrosino
@nl
type
label
Pasquale Ambrosino
@ast
Pasquale Ambrosino
@en
Pasquale Ambrosino
@es
Pasquale Ambrosino
@nl
prefLabel
Pasquale Ambrosino
@ast
Pasquale Ambrosino
@en
Pasquale Ambrosino
@es
Pasquale Ambrosino
@nl
P106
P1153
55208996600
P21
P31
P496
0000-0002-9398-0428